Women’s Health Initiative, known for hormone therapy trials, to lose federal funding

Update: On April 24, the Department of Health and Human Services said it was restoring funding to the Women’s Health Initiative. Read more here.

Federal funding for the Women’s Health Initiative, which as one of the largest research projects in women’s health has shaped treatment of menopause, osteoporosis, and nutrition, will be reduced in September, the program said Tuesday in a message to its 40 regional centers.

The project may be best known for changing the way hormones are prescribed during menopause, when safety data led study leaders to immediately stop hormone therapy given to its trial volunteers. In the decades since, analysis has continued and led to an evolution in treatment. 

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

Individual plans

Group plans

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $399/year

$30 for 3 months Get Started

Then $399/year

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe

Log In